Lupin, one of the leading pharmaceutical companies in India, reported a marginal fall of 1.08% in consolidated net profit for the quarter ended Mar. 31, 2015.

During the quarter net profit stood at Rs 5.47 billion for the quarter ended Mar. 31, 2015 as compared to Rs 5.53 billion in the same period last year.

The company saw a decline of 1.36% in net revenues to Rs 30.78 billion from Rs 31.21 billion in the same quarter last year.

Shares of the company declined Rs 58.65, or 3.35%, to settle  at  Rs 1,690.60.  The total volume of shares traded  was  345,214 at  the BSE (Wednesday).